Kevin F Mclaughlin Adagio Therapeutics, Inc. (ADGI) insider trading activity

Kevin F Mclaughlin is of Adagio Therapeutics, Inc.. Currently has a direct ownership of 50,000 shares of ADGI, which is worth approximately $165,500. The most recent transaction as insider was on Nov 19, 2025, when has been sold 50,000 shares (Common Stock) at a price of $2.5 per share, resulting in proceeds of $125,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 50K

n/a 3M change

n/a 12M change

Total Value Held $165,500

KEVIN F MCLAUGHLIN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Nov 19 2025	BUY Open market or private purchase	$125,000 $2.5 p/Share	50,000 Added 50.0%	50,000 Common Stock

Also insider at

DBTX

Decibel Therapeutics, Inc. Healthcare

Director

XLRN

ACCELERON PHARMA INC Healthcare

SVP, CFO and Treasurer

VCEL

Vericel Corp Healthcare

KFM